Fig. 2From: Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experienceKaplan-Meier plots of survival in patients with metastatic vaginal cancer (n = 11; median, 7.1 months; 95 % CI, 3.2–11 months) and vulvar cancer (n = 16; 4.4 months; 2.6–6.2 months) who underwent phase I trial therapyBack to article page